We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+7.35%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$438M
AUM Growth
+$79M
Cap. Flow
+$165M
Cap. Flow %
37.75%
Top 10 Hldgs %
55.67%
Holding
153
New
56
Increased
27
Reduced
23
Closed
42

Top Buys

Rank Stock Value
1
SMMF
Summit Financial Group, Inc.
SMMF
+$111M
2
NVS icon
Novartis
NVS
+$41.1M
3
RDHL
Redhill Biopharma
RDHL
+$23M
4
JNJ icon
Johnson & Johnson
JNJ
+$20M
5
LLY icon
Eli Lilly
LLY
+$16.7M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$9.18M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$7.75M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$7.1M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.09M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$3.12M

Sector Composition

Rank Sector Weight
1 Healthcare 73.63%
2 Consumer Discretionary 3%
3 Technology 2.66%
4 Industrials 1.84%
5 Consumer Staples 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FPRX
51
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.77M 0.4%
+90,000
New +$1.53M
SMMF
52
DELISTED
Summit Financial Group, Inc.
SMMF
$1.75M 0.4%
+10,921,656
New +$111M
VYX icon
53
NCR Voyix
VYX
$1.14B
$1.75M 0.4%
+77,979
New +$1.66M
CBIO
54
Crescent Biopharma
CBIO
$537M
$1.73M 0.4%
+1,060
New +$1.28M
COST icon
55
Costco
COST
$422B
$1.72M 0.39%
15,409
-12,445
-45% -$1.42M
FLXN
56
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.71M 0.39%
+103,955
New +$1.8M
RXDX
57
DELISTED
Ignyta, Inc.
RXDX
$1.7M 0.39%
+205,000
New +$1.92M
QURE icon
58
uniQure
QURE
$3.03B
$1.55M 0.36%
+100,000
New +$1.59M
GNVC
59
DELISTED
GenVec, Inc.
GNVC
$1.52M 0.35%
+57,500
New +$1.87M
AMPE
60
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$1.43M 0.33%
+750
New +$1.77M
VRTX icon
61
Vertex Pharmaceuticals
VRTX
$121B
$1.41M 0.32%
+20,000
New +$1.58M
CYTR
62
DELISTED
CytRx Corp
CYTR
$1.41M 0.32%
67,500
+15,833
+31% +$562K
RLYP
63
DELISTED
RELYPSA INC COM
RLYP
$1.41M 0.32%
47,300
+17,300
+58% +$625K
IRWD icon
64
Ironwood Pharmaceuticals
IRWD
$696M
$1.39M 0.32%
134,306
-277,624
-67% -$3.12M
TGTX icon
65
TG Therapeutics
TGTX
$7.96B
$1.38M 0.32%
+200,000
New +$1.18M
CTIC
66
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$1.36M 0.31%
+40,000
New +$1.37M
AMBI
67
DELISTED
Ambit Biosciences Corp
AMBI
$1.35M 0.31%
148,468
-85,527
-37% -$908K
BLRX
68
BioLineRX
BLRX
$12.3M
$1.34M 0.31%
+1,000
New +$1.64M
INSM icon
69
Insmed
INSM
$21.4B
$1.33M 0.3%
70,000
+23,000
+49% +$437K
BLUE
70
DELISTED
bluebird bio
BLUE
$1.31M 0.3%
4,434
-2,702
-38% -$819K
OCRX
71
DELISTED
Ocera Therapeutics, Inc.
OCRX
$1.28M 0.29%
121,148
+106,267
+714% +$1.52M
TLOG
72
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$1.28M 0.29%
200,000
+25,000
+14% +$225K
IMMU
73
DELISTED
Immunomedics Inc
IMMU
$1.26M 0.29%
+300,000
New +$1.49M
PLXP
74
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$1.25M 0.29%
+15,625
New +$1.43M
BFH icon
75
Bread Financial
BFH
$4.37B
$1.25M 0.29%
+5,759
New +$1.24M
1 2
3
4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2014 Portfolio in Review

As of Q1 2014, Sphera Funds Management held 153 positions worth $438M, up 22% from $359M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sphera Funds Management deployed $165M of net new capital in Q1 2014, opening 56 new positions and adding to 27 existing holdings. Its largest new stake was Summit Financial Group, Inc.: 10,921,656 shares worth $1.75M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $4.09M trimmed.

  • Sphera Funds Management's largest Q1 2014 buy was Summit Financial Group, Inc.: 10,921,656 shares worth $1.75M.
  • Sphera Funds Management added most to Novartis in Q1 2014, an estimated $41.1M increase.
  • Sphera Funds Management's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $4.09M.
  • Sphera Funds Management fully exited Shire pic in Q1 2014, selling an estimated $9.18M.
  • Sphera Funds Management's ten largest holdings make up 56% of its $438M portfolio in Q1 2014.
  • Sphera Funds Management opened 56 new positions and closed 42 in Q1 2014.
  • Sphera Funds Management's portfolio value rose 22% quarter-over-quarter to $438M.

Based on Sphera Funds Management's 13F filing for Q1 2014, filed 14 May 2014.